Xiangrui Han

TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer

Yohei Sekino, Xiangrui Han, Takafumi Kawaguchi et al. · International Journal of Molecular Sciences · 2019 · 57 citations · Full text

Medicine, Oncology, Pharmacology +17

Microtubule-associated protein tau (MAPT) is a promising independent prognostic marker and tumor suppressive protein in clear cell renal cell carcinoma

Xiangrui Han, Yohei Sekino, Takashi Babasaki et al. · Urologic Oncology Seminars and Original Investigations · 2020 · 33 citations

Medicine, Cancer Biology, Oncology +15

PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell Carcinoma

Yohei Sekino, TAKESHI HAGURA, Xiangrui Han et al. · Anticancer Research · 2020 · 31 citations · Full text

Medicine, Oncology, Pharmacology +17

BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma

Yohei Sekino, Xiangrui Han, Go Kobayashi et al. · Oncology · 2021 · 31 citations

Medicine, Genetics, Oncology +17

Microtubule-associated protein tau (MAPT) promotes bicalutamide resistance and is associated with survival in prostate cancer

Yohei Sekino, Xiangrui Han, Takashi Babasaki et al. · Urologic Oncology Seminars and Original Investigations · 2020 · 26 citations

Medicine, Oncology, Pharmacology +16